You are here

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

Last updated on February 18, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Chronic Kidney Failure, Graft vs Host Disease, Kidney Transplantation
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
13 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Age: 13 years or older, 40 kgs or more

- End-stage renal disease

- African-American/Black transplant recipient and/or repeat renal transplant recipient
who lost a previous allograft

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Evidence of active infection

- Evidence abnormal chest x-ray

- Patients with HIV.

NCT00044720
Pfizer
Completed
Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Kidney Transplantation
NCT00484094
All Genders
13+
Years
Multiple Sites
Kidney Failure, Graft vs Host Disease
NCT00195429
All Genders
13+
Years
Sao Paulo,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now